Investors bought shares of CVS Health Corporation (NYSE:CVS) on weakness during trading hours on Thursday. $77.55 million flowed into the stock on the tick-up and $44.94 million flowed out of the stock on the tick-down, for a money net flow of $32.61 million into the stock. Of all companies tracked, CVS Health Corporation had the 39th highest net in-flow for the day. CVS Health Corporation traded down ($0.03) for the day and closed at $93.37

Several equities analysts have recently commented on CVS shares. Credit Suisse Group AG reissued a “buy” rating and issued a $115.00 target price on shares of CVS Health Corporation in a report on Sunday, June 5th. Morgan Stanley reissued a “hold” rating and issued a $104.00 target price on shares of CVS Health Corporation in a report on Wednesday, August 3rd. Jefferies Group reissued a “buy” rating on shares of CVS Health Corporation in a report on Monday, July 4th. FBR & Co reissued an “outperform” rating and issued a $120.00 target price on shares of CVS Health Corporation in a report on Wednesday, August 3rd. Finally, Citigroup Inc. boosted their target price on shares of CVS Health Corporation from $105.00 to $115.00 and gave the stock a “neutral” rating in a report on Monday, May 9th. Six analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the company. CVS Health Corporation has a consensus rating of “Buy” and a consensus target price of $113.02.

The firm’s 50 day moving average price is $95.95 and its 200-day moving average price is $98.51. The stock has a market cap of $99.55 billion and a price-to-earnings ratio of 21.48.

CVS Health Corporation (NYSE:CVS) last posted its quarterly earnings results on Tuesday, August 2nd. The pharmacy operator reported $1.32 EPS for the quarter, topping the consensus estimate of $1.30 by $0.02. During the same quarter in the prior year, the firm earned $1.19 EPS. The company had revenue of $43.70 billion for the quarter, compared to analysts’ expectations of $44.28 billion. The firm’s revenue was up 17.6% on a year-over-year basis. On average, equities analysts predict that CVS Health Corporation will post $5.86 earnings per share for the current fiscal year.

Several hedge funds and institutional investors recently bought and sold shares of the company. Principal Financial Group Inc. raised its position in CVS Health Corporation by 1.5% in the fourth quarter. Principal Financial Group Inc. now owns 1,676,916 shares of the pharmacy operator’s stock valued at $163,952,000 after buying an additional 24,602 shares in the last quarter. Bank of Montreal Can raised its stake in shares of CVS Health Corporation by 0.4% in the fourth quarter. Bank of Montreal Can now owns 4,967,220 shares of the pharmacy operator’s stock valued at $485,648,000 after buying an additional 19,949 shares during the period. Liberty Mutual Group Asset Management Inc. raised its stake in shares of CVS Health Corporation by 58.8% in the fourth quarter. Liberty Mutual Group Asset Management Inc. now owns 65,866 shares of the pharmacy operator’s stock valued at $6,440,000 after buying an additional 24,391 shares during the period. Atlantic Trust Group LLC raised its stake in shares of CVS Health Corporation by 6.5% in the fourth quarter. Atlantic Trust Group LLC now owns 1,402,695 shares of the pharmacy operator’s stock valued at $137,141,000 after buying an additional 85,136 shares during the period. Finally, Olstein Capital Management L.P. raised its stake in shares of CVS Health Corporation by 42.2% in the fourth quarter. Olstein Capital Management L.P. now owns 64,000 shares of the pharmacy operator’s stock valued at $6,257,000 after buying an additional 19,000 shares during the period.

CVS Health Corporation, together with its subsidiaries, is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.